{
  "source": "twitter",
  "source_id": "003",
  "url": "https://twitter.com/metabolic_research/status/003",
  "title": null,
  "text": "Our latest study on post-bariatric hypoglycemia published in JAMA. 127 patients post-RYGB evaluated for PBH symptoms. 34% presented with severe hypoglycemic episodes <50mg/dL. Acarbose showed 67% efficacy in symptom reduction. Novel GLP-1 antagonist therapies showing promise. Link to full paper: [redacted] #BariatricResearch #Endocrinology",
  "parent_source": null,
  "subsource": null,
  "author": {
    "id": "twitter_user_003",
    "name": "User c",
    "handle": "user_c",
    "gender": "male",
    "age": 45,
    "subscribers": 12500
  },
  "country": "US",
  "language": "eng",
  "metrics": {
    "likes": 234,
    "comments": 45,
    "shares": 89
  },
  "sentiment": null,
  "published_at": "2025-05-12T09:15:00+00:00"
}